Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -36.84M | -32.18M | -57.01M | -58.56M | -63.5M | -57.76M | -54.06M | -54.29M | -47.22M | -50.33M | -41.51M | -34.15M | -33.05M |
Depreciation & Amortization | 583K | 576K | 573K | 575K | 589K | 597K | 590K | 597K | 603K | 620K | 641K | 626K | 608K |
Stock-Based Compensation | 12.07M | 10.63M | 10.3M | 10.2M | 9.91M | 9.65M | 8.64M | 7.72M | 6.93M | 6.24M | 5.73M | 5.06M | 4.75M |
Other Working Capital | -48.27M | -49.67M | -24.91M | -26.85M | -20.05M | -25.97M | -28.66M | 19.64M | 13.68M | 23.03M | 26.66M | -15.28M | 53.29M |
Other Non-Cash Items | -7.38M | -6.32M | -5.08M | -2.92M | -2.73M | -588K | 1.32M | 1.31M | 1.17M | 796K | 282K | 282K | 289K |
Deferred Income Tax | -1.55M | -1.55M | -1.66M | -1.66M | 159K | 159K | -101K | 148K | 170K | 388K | 770K | 513K | 367K |
Change in Working Capital | -47.43M | -50.16M | -23.95M | -25.01M | -19.79M | 4.19M | 1.92M | 49.3M | 44.52M | 27.04M | 24.22M | -17.73M | 50.84M |
Operating Cash Flow | -80.55M | -79.01M | -76.83M | -77.38M | -75.36M | -43.75M | -41.7M | 4.79M | 6.17M | -15.25M | -9.87M | -45.39M | 23.81M |
Capital Expenditures | -413K | -487K | -489K | -543K | -479K | -412K | -345K | -290K | -105K | -118K | -557K | -617K | -785K |
Cash Acquisitions | 83.52M | 55.07M | 50.27M | 23.89M | 46.72M | 75.16M | -32.62M | -6.78M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -392.39M | -351.35M | -335.91M | -288.32M | -255.06M | -266.98M | -153.9M | -200.39M | -169.89M | -133.52M | -196.32M | -111.97M | -106.32M |
Sales Maturities Of Investments | 306.33M | 296.27M | 285.64M | 264.44M | 208.34M | 154.05M | 144.51M | 102.64M | 86.26M | 81.16M | 22.52M | 2.59M | -14.7M |
Other Investing Acitivies | -83.52M | -55.07M | -50.27M | -23.89M | -46.72M | -112.94M | -9.39M | -97.75M | -83.63M | -52.36M | -18.82M | 45.6M | 33.96M |
Investing Cash Flow | -86.47M | -55.56M | -50.76M | -24.43M | -47.2M | -113.35M | -9.73M | -98.04M | -83.74M | -52.48M | -145.04M | -80.69M | -92.5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11K | -11K | -11K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 185.56M | 165.12M | 20.05M | 111.67M | 102.25M | 102.69M | 102.02M | 98.88M | 99.91M | 100.76M | 89.88M | 56.59M | 56.58M |
Financial Cash Flow | 185.56M | 165.12M | 20.05M | 111.67M | 102.25M | 102.69M | 102.02M | 98.88M | 99.91M | 100.76M | 89.88M | 56.59M | 56.58M |
Net Cash Flow | 18.55M | 30.55M | -107.64M | 9.72M | -20.42M | -54.53M | 50.53M | 5.55M | 22.26M | 32.95M | -64.98M | -69.41M | -11.95M |
Free Cash Flow | -80.96M | -79.5M | -77.32M | -77.92M | -75.83M | -44.17M | -42.04M | 4.5M | 6.07M | -15.37M | -10.43M | -46.01M | 23.02M |